Skip to Content

832 WRF 7 1/2 (Jantoven 7.5 mg)

Generic Name: warfarin

Pill with imprint 832 WRF 7 1/2 is Yellow, Round and has been identified as Jantoven 7.5 mg. It is supplied by Upsher-Smith Laboratories, Inc.

Jantoven is used in the treatment of antiphospholipid syndrome; deep vein thrombosis prophylaxis after knee replacement surgery; deep vein thrombosis prophylaxis after hip replacement surgery; chronic central venous catheterization; deep vein thrombosis, first event and belongs to the drug class coumarins and indandiones. For women with mechanical heart valves: There is positive evidence of human fetal risk during pregnancy. For other pregnant populations: Not for use in pregnancy. Jantoven 7.5 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for 832 WRF 7 1/2

Jantoven 7.5 mg 832 WRF 7 1/2

Jantoven

Generic Name
warfarin
Imprint
832 WRF 7 1/2
Strength
7.5 mg
Color
Yellow
Size
9.00 mm
Shape
Round
Availability
Prescription only
Drug Class
Coumarins and indandiones
Pregnancy Category
D - Positive evidence of risk - for women with mechanical heart valves, X - Not for use in pregnancy - for other pregnant populations
CSA Schedule
Not a controlled drug
Labeler / Supplier
Upsher-Smith Laboratories, Inc
National Drug Code (NDC)
00832-1218
Inactive Ingredients
lactose monohydrate, magnesium stearate, corn starch, D&C Yellow No. 10, FD&C Yellow No. 6

Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.